Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
474 participants
OBSERVATIONAL
2017-10-14
2023-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life Assessment Before and After Essure Removal
NCT03401437
Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
NCT03127722
vNOTES Transvaginal Endoscopic Surgery Versus Laparoscopy
NCT04324034
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology
NCT03187327
Proportion of Hysterectomy After Female Sterilization
NCT02532361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Essure®
Patients with laparoscopic removal of Essure®
Quality of life after Essure® removal
Questionnaire to assess the quality of life 1, 3, 6 and 12 months after laparoscopic removal of Essure® device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of life after Essure® removal
Questionnaire to assess the quality of life 1, 3, 6 and 12 months after laparoscopic removal of Essure® device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with Essure® sterilization device
* surgical removal of Essure® with bilateral salpingectomy by laparoscopy
Exclusion Criteria
* impaired lower-limb range of motion preventing positioning for surgery
* inability to understand information provided
* prisoner or under administrative supervision.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Trecourt A, Devouassoux-Shisheboran M, Nohuz E, Cerruto E, Moret S, Hallez D, Miguet-Bensouda C, Chene G. Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure(R) implant removal: a cross-sectional study. Eur J Contracept Reprod Health Care. 2023 Aug;28(4):227-233. doi: 10.1080/13625187.2023.2218953. Epub 2023 Jun 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL17_0479
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.